Skip to content

Blogs

AI – The driving force to transform healthcare

17 June 2021

Biological medicines are now the largest and fastest growing segment of the pharmaceutical industry and the market is valued at over $250bn. The ability of biological medicines to target diseases...

Read More

Valita®TITER – a novel plug-and-play IgG quantification tool for Bi-specific antibody screening

20 March 2021 Read More

Clone stability in bioprocessing: Cell Phenotypic profiling to crack misleading apparent stability

20 March 2021 Read More

Clone stability in bioprocessing: A deep dive into current clone stability trials

20 March 2021 Read More

Robust IgG measurement in bioprocessing: How ValitaCell are supporting the changing landscape of antibody therapeutics

20 March 2021 Read More

Robust IgG measurement in bioprocessing: Rapid, accurate and robust IgG measurement in the presence of cells

20 March 2021 Read More

Cell culture media in bioprocessing: Why we need biological metrics to understand media variation in bioprocessing

20 March 2021 Read More
Load More